<DOC>
	<DOCNO>NCT02228707</DOCNO>
	<brief_summary>The primary objective study evaluate safety tolerability multiple dos BIIB061 administer healthy adult . The secondary objective determine multiple-dose PK profile BIIB061 study population .</brief_summary>
	<brief_title>Study Assess Safety , Tolerability , Pharmacokinetics BIIB061 Healthy Adult Volunteers</brief_title>
	<detailed_description />
	<criteria>Key Males postmenopausal ( defined menses 12 month confirm folliclestimulating hormone [ FSH ] level determine screen postmenopausal range ) surgically sterile female Must good health normal vital sign determine Investigator , base medical history screening evaluation . Must agree abstain alcohol ingestion duration study . Must agree abstain consumption grapefruit grapefruitcontaining product duration study , start least 24 hour prior admission inpatient facility . Must agree abstain take St. John 's Wort ( herbal preparation ) duration study Must agree abstain vigorous exercise ( determined Investigator ) duration study . Must body mass index 18 30 kg/m2 , inclusive . Key History positive test result screen human immunodeficiency virus , hepatitis C virus antibody , hepatitis B virus ( define positive hepatitis B surface antigen [ HBsAg ] hepatitis B core antibody [ HBcAb ] ) . Presence metal device ( e.g. , type electronic , mechanical , magnetic implant ; cardiac pacemaker ; aneurysm clip ; implant cardiac defibrillator ) potential ferromagnetic foreign body ( metal sliver , metal shaving , metal object ) contraindication MRI . History asthma , wheeze , allergy involve lung , airway obstruction . History bronchodilator inhaler use . Clinically significant abnormal hematology blood chemistry value , determine Investigator . Inability unwillingness comply study requirement . Other unspecified reason , opinion Investigator Biogen Idec , make subject unsuitable enrollment . Note : Other protocol define inclusion/ exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>